Arrowgrass Capital Partners (US)’s CVS Health CVS Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-32,745	Closed	-$2.38M	–	521
2017 Q3	$2.66M	Sell	32,745 -106,419	-76%	-$8.42M	0.02%	421
2017 Q2	$11.2M	Buy	139,164 +404	+0.3%	+$31.9K	0.09%	287
2017 Q1	$10.9M	Buy	138,760 +73,268	+112%	+$5.85M	0.11%	230
2016 Q4	$5.17M	Sell	65,492 -12,584	-16%	-$1.02M	0.06%	261
2016 Q3	$6.95M	Buy	78,076 +56,171	+256%	+$5.3M	0.09%	169
2016 Q2	$2.1M	Buy	21,905 +21,721	+11,805%	+$2.16M	0.02%	277
2016 Q1	$19K	Sell	184 -54,055	-100%	-$5.26M	﹤0.01%	390
2015 Q4	$5.3M	Buy	54,239 +24,301	+81%	+$2.38M	0.06%	159
2015 Q3	$2.89M	Buy	29,938 +18,030	+151%	+$1.9M	0.05%	211
2015 Q2	$1.25M	Buy	+11,908	New	+$1.22M	0.02%	390

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s CVS Position: Q4 2017 in Review

Arrowgrass Capital Partners (US) sold out of CVS Health (CVS) in Q4 2017, closing a stake of 32,745 shares — an estimated $2.38M sold.

Arrowgrass Capital Partners (US) first reported a position in CVS in Q2 2015 and held it in 10 quarters. The position peaked at $11.2M in Q2 2017. 1,598 funds tracked by Wall St. Rank hold CVS as of Q4 2017.

Arrowgrass Capital Partners (US) reported no remaining CVS Health position as of Q4 2017 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 32,745 CVS Health shares in Q4 2017, an estimated $2.38M.
Arrowgrass Capital Partners (US) first reported a position in CVS Health in Q2 2015 and held it in 10 quarters.
Arrowgrass Capital Partners (US)'s CVS Health position peaked at $11.2M in Q2 2017.
1,598 funds tracked by Wall St. Rank held CVS Health as of Q4 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2017, filed 14 Feb 2018.